美国Buxco Research Systems   
四十多年来，作为临床前肺功能研究领域的技术创新领导者，美国Buxco公司始终为世界顶级医药科研机构和科学家们提供领先业界的专利创新产品及解决方案，至今成功地保持着全球市场占有率第一的荣誉。我们不仅提供完善细致的售后服务，还主动提供学术和技术上的支持。与用户卓有成效的沟通和互动，是Buxco不断创新并引领该领域实验技术与设备发展方向的成功秘诀。
.
您对Buxco的信赖和选择，是我们不断发展的源动力！
.
您可以在以下研究领域得到我们的支持和帮助：
.
Phenotyping                                                                   显型表现型快速筛选
.
Asthma                                                                          哮喘
.
COPD                                                                           慢阻肺
.
Pulmonary diseases                                                        各种肺部疾病研究
.
Drug development                                                          新药研究及筛选、药理药效分析
.
Metabolism                                                                    药物代谢
.
Toxicology                                                                    药物毒理及安全性分析
.
Immunology                                                                  免疫学研究
.
Cardiovascular                                                               心血管系统研究
.
Edema                                                                          水肿

Buxco Research Systems

Buxco has been a leading innovator in pre-clinical life science research for more than 40 years. We work as your engineering partner to develop complete data acquisition and analysis solutions integrating software, hardware, application knowledge, and after-sale support. Applications cover pulmonary, cardiovascular, metabolic, and isolated organ research.

Buxco's FinePointe™ software provides the industry's most advanced platform for all of these applications. Our set of software analyzers work individually or together to quantify key physiological parameters.

FinePointe™ software allows researchers to acquire, evaluate, and reanalyze data sets; set, move, and resize measurement periods; summarize data by subject groups; and generate statistical reports.

Our hardware is widely-used and covers a broad spectrum of research needs. Plethysmographs; transducers, sensors, and probes; preamplifiers; A/D converters; aerosol components; gas analyzers; and more; all fit together and are designed specifically for pre-clinical research.

Buxco's systems are cited extensively in published research so you can be assured your work fits into a large body of pre-clinical discovery.

For decades Buxco has driven innovation in the pre-clinical research market. That spirit of innovation continues with the introduction of our FinePointe™ series integrated systems, our Halcyon™ pneumotachographs, and the coming introduction of FinePointe™ NAM for noninvasive airway mechanics.

Buxco is headquartered in Wilmington, North Carolina USA and operates from locations across the United States, the United Kingdom, Japan, China, and Singapore. Other regions are served by a network of authorized technical distributors.